CN116239558A - Preparation method of eriodictyol - Google Patents
Preparation method of eriodictyol Download PDFInfo
- Publication number
- CN116239558A CN116239558A CN202310124173.3A CN202310124173A CN116239558A CN 116239558 A CN116239558 A CN 116239558A CN 202310124173 A CN202310124173 A CN 202310124173A CN 116239558 A CN116239558 A CN 116239558A
- Authority
- CN
- China
- Prior art keywords
- reaction
- eriodictyol
- solution
- solvent
- reducing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 title claims abstract description 38
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 235000011797 eriodictyol Nutrition 0.000 title claims abstract description 38
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 title claims abstract description 38
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 30
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 22
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000010209 hesperetin Nutrition 0.000 claims abstract description 22
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 claims abstract description 22
- 229960001587 hesperetin Drugs 0.000 claims abstract description 22
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000007810 chemical reaction solvent Substances 0.000 claims abstract description 19
- 239000000543 intermediate Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 239000007806 chemical reaction intermediate Substances 0.000 claims abstract description 11
- 239000007800 oxidant agent Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 230000001590 oxidative effect Effects 0.000 claims abstract description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 72
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 40
- 239000007787 solid Substances 0.000 claims description 35
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 34
- 239000002904 solvent Substances 0.000 claims description 29
- 238000005406 washing Methods 0.000 claims description 20
- 238000004537 pulping Methods 0.000 claims description 18
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 17
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 5
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 2
- FIYYMXYOBLWYQO-UHFFFAOYSA-N ortho-iodylbenzoic acid Chemical group OC(=O)C1=CC=CC=C1I(=O)=O FIYYMXYOBLWYQO-UHFFFAOYSA-N 0.000 claims description 2
- 239000012071 phase Substances 0.000 claims description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims 1
- 238000005580 one pot reaction Methods 0.000 abstract description 8
- 238000000746 purification Methods 0.000 abstract description 7
- 230000033116 oxidation-reduction process Effects 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 239000012043 crude product Substances 0.000 description 16
- 238000002390 rotary evaporation Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 13
- 238000001914 filtration Methods 0.000 description 9
- -1 flavonoid compound Chemical class 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000010189 synthetic method Methods 0.000 description 9
- 239000005711 Benzoic acid Substances 0.000 description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 8
- 235000010233 benzoic acid Nutrition 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000007966 viscous suspension Substances 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 5
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
Abstract
The invention discloses a preparation method of eriodictyol, which comprises the following steps: the hesperetin reacts with an oxidant in a reaction solvent to obtain a reaction intermediate solution, and a reducing agent is added into the reaction intermediate solution to obtain the eriodictyol. The preparation method disclosed by the invention has the advantages of wide raw material sources, low cost, easiness in obtaining, no operation danger and stable property, the reaction condition is mild, the one-pot product is realized by one-pot oxidation reduction, no intermediate step treatment and purification are needed, the whole post-treatment operation after the reaction is finished is very simple and easy, and the subsequent production scale is conveniently amplified.
Description
Technical Field
The invention belongs to the technical field of synthesis of organic medical intermediates, and particularly relates to a preparation method of eriodictyol.
Background
Eriodictyol is a flavonoid compound isolated from herbs and has antioxidant, antiinflammatory, analgesic, and diabetes and diabetic complications improving effects. The synthesis methods reported in the current literature mainly comprise two methods; the first method is to obtain eriodictyol by taking luteolin as a raw material and methanol as a solvent, reducing double bonds by palladium-carbon hydrogenation, and performing post-treatment through silica gel column purification, wherein the reaction formula is as follows:
the second is to take hesperetin as a raw material, pyridine as a solvent, add anhydrous aluminum chloride and heat at 70 ℃, and then treat with hydrochloric acid to obtain eriodictyol, wherein the reaction formula is as follows:
in the first method, a metallic palladium catalyst is required to be used for reduction, a product with a non-absolute configuration is obtained, and further chiral resolution is required to be carried out to obtain the product with the absolute configuration, so that the method is inconvenient in terms of experimental steps and purification difficulty; in the second method, anhydrous aluminum chloride which is extremely easy to absorb moisture and has strong corrosiveness is required to be used for demethylation, the use of a large amount of aluminum trichloride can lead to quite complex post-treatment, intense heat release is required during water quenching, great care is required, the generated aluminum salt can lead to serious emulsification phenomenon, great trouble is caused to the subsequent extraction step, and a large amount of corrosive waste liquid is generated. Therefore, the method has great limitation in terms of economy, environmental protection and large-scale synthesis.
Therefore, it is necessary to research and develop an eriodictyol preparation method which has the advantages of wide raw material sources, low cost, easy availability, no operation danger, stable property, simple and easy post-treatment and convenient subsequent scale-up.
Disclosure of Invention
The preparation method provided by the invention has the advantages of wide raw material sources, low cost, easiness in obtaining, no operation danger and stable property, the reaction condition is mild, the one-pot product is realized by one-pot oxidation reduction, the treatment of intermediate steps is not needed, the purification is not needed, the whole post-treatment operation after the reaction is finished is very simple and easy, and the subsequent production scale is conveniently amplified.
The invention provides a preparation method of eriodictyol, which comprises the following steps: the hesperetin reacts with an oxidant in a reaction solvent to obtain a reaction intermediate solution, and a reducing agent is added into the reaction intermediate solution to obtain the eriodictyol.
The synthetic route of the preparation method of eriodictyol in the invention is as follows:
the synthetic reaction mechanism of eriodictyol in the present invention is as follows:
in one embodiment of the invention, the intermediate solution is obtained by the following steps: and adding the raw material hesperetin into a reaction solvent, adding an oxidant at one time, protecting a reaction system by using inert gas, and reacting for 24 hours at room temperature to complete the conversion of a reaction intermediate state, thereby obtaining a reaction intermediate state solution.
Preferably, the oxidizing agent is 2-iodoxybenzoic acid.
Preferably, the reaction solvent is at least one of tetrahydrofuran, dioxane or N, N-dimethylformamide.
Preferably, the ratio of the reaction solvent to the raw material hesperetin is 30mL/g.
In one embodiment of the present invention, the step of adding a reducing agent to the intermediate solution for reaction to obtain eriodictyol comprises the steps of: ice bath for 0.5h, preparing aqueous solution of reducing agent, adding aqueous solution of reducing agent into the intermediate solution, continuously ice bath for 0.5h, removing ice bath, reacting for 3h at room temperature, distilling to remove reaction solvent, adding saturated ammonium chloride solution into the rest water phase, extracting with ethyl acetate, mixing organic phases, washing saturated sodium bicarbonate solution, washing saturated saline solution, drying with anhydrous sodium sulfate, distilling to remove solvent to obtain yellow solid, adding the solid into mixed solvent of methanol and ethyl acetate, repeatedly pulping for 2-3 times to obtain eriodictyol.
Preferably, the reducing agent is at least one of sodium dithionite, sodium bisulphite or sodium thiosulfate.
Preferably, the aqueous solution concentration of the reducing agent is 0.2g/mL.
Preferably, in the mixed solvent of methanol and ethyl acetate, the volume ratio of the methanol to the ethyl acetate is 1:10.
compared with the prior art, the invention has the following beneficial effects:
1. all raw materials in the preparation method of the invention have wide sources, low cost and easy availability, and all raw materials have no operation danger and stable properties.
2. The preparation method has mild reaction conditions and simple subsequent purification treatment.
3. The preparation method of the invention realizes one-pot product discharge through one-pot oxidation reduction, does not need intermediate steps for treatment and purification, and has the advantages of very simple and easy operation of the whole post-treatment operation after the reaction is finished, and convenient amplification of the subsequent production scale.
Of course, it is not necessary for any one product to practice the invention to achieve all of the advantages set forth above at the same time.
Drawings
FIG. 1 is a nuclear magnetic resonance spectrum of eriodictyol prepared in example 1;
FIG. 2 is a high performance liquid chromatography purity chart of eriodictyol obtained in example 1.
Detailed Description
In this document, a range from "one value to another value" is a shorthand way of referring individually to all the values in the range, which are avoided in the specification. Thus, recitation of a particular numerical range includes any numerical value within that range, as well as the smaller numerical range bounded by any numerical value within that range, as if the any numerical value and the smaller numerical range were written in the specification in the clear.
The raw materials and reagents used in the examples of the present invention are commercially available, and in the present invention, "under room temperature" means a temperature range of 20℃to 30℃and "under ice bath" means a temperature range of 5℃to 10 ℃.
The synthetic method of eriodictyol comprises the following reaction equation:
the preparation method of the invention realizes one-pot product discharge through one-pot oxidation reduction, does not need intermediate steps for treatment and purification, and has the advantages of very simple and easy operation of the whole post-treatment operation after the reaction is finished, and convenient amplification of the subsequent production scale.
The invention will be further illustrated with reference to specific examples. It should be understood that these examples are illustrative of the present invention and are not intended to limit the scope of the present invention. The range of parameters that can be implemented by the present invention is not limited by the specific examples given in the following examples. Modifications and adaptations of the invention will occur to those skilled in the art and are intended to be within the scope of the invention in practice.
Example 1
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (17.3 g,99.36 mmol) is dissolved in water (86.5 mL) and poured into the reaction for a small amount for many times, and the mixture is stirred for 0.5h continuously and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain crude yellow solid 4.1g;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by pulping at last is filtered out, and the solid is collected and dried to obtain white solid (1.75 g,36.6% yield) with the purity reaching 100%.
LC-MS(UV 214):289.00(M+H) + (100%purity); 1 H NMR(400MHz,dmso-d6)δ12.12(s,1H),10.75(s,1H),9.02(d,J=17.2Hz,2H),6.79(d,J=51.9Hz,3H),5.86(s,2H),5.36(d,J=10.1Hz,1H),3.17(dd,J=17.1,12.6Hz,1H),2.66(d,J=14.6Hz,1H)。
Example 2
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and dioxane (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (17.3 g,99.36 mmol) is dissolved in water (86.5 mL) and poured into the reaction for a small amount for many times, and the mixture is stirred for 0.5h continuously and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of dioxane by using rotary steaming;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain crude yellow solid 4.0g;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by pulping at last is filtered out, and the collected solid is dried to obtain white solid (1.67 g, product yield 35.1%) with purity up to 97%. LC-MS (UV 214): 289.0 (M+H) + ;RT=1.604min;97%purity。
Example 3
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and ethylene glycol dimethyl ether (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (17.3 g,99.36 mmol) is dissolved in water (86.5 mL) and poured into the reaction for a small amount for many times, and the mixture is stirred for 0.5h continuously and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of ethylene glycol dimethyl ether by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain 3.8g of crude yellow solid;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by pulping at last is filtered out, and the solid is collected and dried to obtain white solid (1.6 g, product yield 33.7%), the purity of which reaches 98.92%. LC-MS (UV 214): 289.0 (M+H) + ;RT=1.613min;98.92%purity。
Example 4
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium thiosulfate (15.7 g,99.36 mmol) is dissolved in water (86.5 mL), and a small amount of sodium thiosulfate is poured into the reaction for many times, and is stirred for 0.5h continuously under ice bath condition, and then naturally warmed to room temperature and stirred for 3h, thus obtaining yellow clarified liquid; the mole ratio of the raw material hesperetin to the reducing agent is 1:6, preparing a base material;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain 3.5g of crude yellow solid;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by pulping at last is filtered out, and the solid is collected and dried to obtain white solid (1.34 g, product yield 28.1%), and LC-MS purity reaches 98.35%. LC-MS (UV 214): 289.0 (M+H) + ;RT=1.617min;98.35%purity。
Example 5
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium bisulphite (10.33 g,99.36 mmol) is dissolved in water (86.5 mL), and a small amount of sodium bisulphite is poured into the reaction for many times, and the mixture is stirred for 0.5h continuously under ice bath condition and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain crude yellow solid 2.5g;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by the last pulping is filtered off, and the solid is collected and dried to obtain a white solid (0.96 g, product yield 20.1%, LC-MS purity up to 100%). LC-MS (UV 214): 289.0 (M+H) + ;RT=1.678min;100%purity。
The mole ratio of the raw material hesperetin to the reducing agent is 1:6.
example 6
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (8.65 g,49.68 mmol) is dissolved in water (43 mL), and a small amount of sodium dithionite is poured into the reaction for many times, and the mixture is stirred for 0.5h under ice bath condition, then naturally warmed to room temperature and stirred for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain crude yellow solid 4.1g;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by the last pulping is filtered off, and the solid is collected and dried to obtain a white solid (0.82 g, 17.1% yield of product, 100% purity of LC-MS). LC-MS (UV 214): 289.10 (M+H) + ;RT=1.644min;100%purity。
The mole ratio of the raw material hesperetin to the reducing agent is 1:3.
example 7
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (14.4 g,82.8 mmol) is dissolved in water (72 mL), and a small amount of sodium dithionite is poured into the reaction for many times, and the mixture is stirred for 0.5h continuously under ice bath condition and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain 3.6g of crude yellow solid;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: filtering out the solid obtained by pulping, and collecting the solidOven drying gave a white solid (1.45 g, 30.4% yield of product, 99.6% purity LC-MS). LC-MS (UV 214): 289.20 (M+H) + ;RT=1.636min;99.6%purity。
The mole ratio of the raw material hesperetin to the reducing agent is 1:5.
example 8
The embodiment provides a synthetic method of eriodictyol, comprising the following steps:
step 1: hesperetin (5.0 g,16.56 mmol) and tetrahydrofuran (150 mL) were mixed and dissolved at room temperature;
step 2: 2-iodate acyl benzoic acid (10.2 g,36.43 mmol) was added at a time, and the mixture was stirred for 24 hours under nitrogen protection to give a dark red viscous suspension (intermediate reaction solution);
step 3: the dark red thick suspension is kept for 0.5h under ice bath condition, sodium dithionite (20.1 g,115.9 mmol) is dissolved in water (100 mL), and a small amount of sodium dithionite is poured into the reaction for many times, and the mixture is stirred for 0.5h continuously under ice bath condition and then naturally heated to room temperature for stirring for 3h, thus obtaining yellow clarified liquid;
step 4: removing most of tetrahydrofuran by rotary evaporation;
step 5: pouring saturated ammonium chloride solution (30 mL), extracting with ethyl acetate (60 mL x 3), washing the combined organic phases with saturated sodium bicarbonate solution (30 mL x 3), washing with saturated saline (20 mL x 1), drying over anhydrous sodium sulfate, filtering, and removing the solvent by rotary evaporation to obtain crude yellow solid 4.0g;
step 6: adding the crude product into a solvent with the mixing ratio of methanol to ethyl acetate of 1:10, and pulping repeatedly for three times, wherein the mass ratio of the solvent to the crude product is 6-8 mL/g;
step 7: the solid obtained by the last pulping was filtered off, the solid was collected and dried to give a white solid (1.7 g, product yield 35.5%, LC-MS purity 99.9%). LC-MS (UV 214): 289.0 (M+H) + ;RT=1.681min;99.9%purity。
The mole ratio of the raw material hesperetin to the reducing agent is 1:7.
the present invention has been made by the above-described studies of examples 1 to 8, and the detailed results of the study on the reaction solvent, the kind of reducing agent and the amount of reducing agent used in the reaction in the present invention are shown below:
1. influence of the reaction solvent on the yield of the product
Examples 1 to 3 differ only in the reaction solvent, tetrahydrofuran was used as the reaction solvent in example 1, dioxane was used as the reaction solvent in example 2, and ethylene glycol dimethyl ether was used as the reaction solvent in example 3.
TABLE 1 influence of reaction solvent on product yield
As is clear from Table 1, the different solvents have less influence on the reaction, and tetrahydrofuran is preferable as the reaction solvent in the present invention because tetrahydrofuran can be easily removed by rotary evaporation in view of its low boiling point and can be easily worked up.
2. Influence of the kind and amount of the reducing agent on the yield of the product
Examples 1 and 4-5 differ in the specific choice of reducing agent, sodium dithionite in example 1, sodium thiosulfate in example 4 and sodium bisulfite in example 5. Examples 1 and 6-8 differ in the molar ratio of the starting material hesperetin to the reducing agent.
TABLE 2 influence of the type and amount of reducing agent on the yield of the product
As can be seen from the above table, sodium dithionite is used as the reducing agent for the reaction, the yield is highest, and sodium dithionite is economical and practical, so sodium dithionite is preferred in the present invention as the reducing agent; from the aspect of reducing agent consumption, when sodium dithionite is used as the reducing agent, the reaction yield is gradually increased along with the increase of the consumption; however, since the reaction yield does not significantly increase after the amount of the reducing agent is 6 equivalents, the amount of the reducing agent is preferably 6 equivalents in view of the problems of the reaction yield and the cost.
The foregoing describes specific embodiments of the present invention. It is to be understood that the invention is not limited to the particular embodiments described above, and that various changes or modifications may be made by those skilled in the art within the scope of the appended claims without affecting the spirit of the invention. The embodiments of the present application and features in the embodiments may be combined with each other arbitrarily without conflict.
Claims (9)
1. A method for preparing eriodictyol, comprising the steps of: the hesperetin reacts with an oxidant in a reaction solvent to obtain a reaction intermediate solution, and a reducing agent is added into the reaction intermediate solution to obtain the eriodictyol.
2. The process for producing eriodictyol according to claim 1, wherein the reaction intermediate solution is obtained by specifically: and adding the raw material hesperetin into a reaction solvent, adding an oxidant at one time, protecting a reaction system by using inert gas, and reacting for 24 hours at room temperature to complete the conversion of a reaction intermediate state, thereby obtaining a reaction intermediate state solution.
3. The process for producing eriodictyol according to claim 2, wherein the oxidizing agent is 2-iodoxybenzoic acid.
4. The process for producing eriodictyol according to claim 3, wherein the reaction solvent is at least one of tetrahydrofuran, dioxane or N, N-dimethylformamide.
5. The process for producing eriodictyol according to claim 3, wherein the ratio of the reaction solvent to the raw hesperetin is 30mL/g.
6. The process for producing eriodictyol according to any one of claims 1 to 5, wherein the step of adding a reducing agent to the intermediate solution for reaction to give eriodictyol comprises the steps of: ice bath for 0.5h, preparing aqueous solution of reducing agent, adding aqueous solution of reducing agent into the intermediate solution, continuously ice bath for 0.5h, removing ice bath, reacting for 3h at room temperature, distilling to remove reaction solvent, adding saturated ammonium chloride solution into the rest water phase, extracting with ethyl acetate, mixing organic phases, washing saturated sodium bicarbonate solution, washing saturated saline solution, drying with anhydrous sodium sulfate, distilling to remove solvent to obtain yellow solid, adding the solid into mixed solvent of methanol and ethyl acetate, repeatedly pulping for 2-3 times to obtain eriodictyol.
7. The method for producing eriodictyol according to claim 6, wherein the reducing agent is at least one of sodium dithionite, sodium hydrogen sulfite or sodium thiosulfate.
8. The process for producing eriodictyol according to claim 6, wherein the aqueous solution of the reducing agent has a concentration of 0.2g/mL.
9. The process for producing eriodictyol according to claim 6, wherein the volume ratio of methanol to ethyl acetate in the mixed solvent of methanol and ethyl acetate is 1:10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310124173.3A CN116239558A (en) | 2023-02-16 | 2023-02-16 | Preparation method of eriodictyol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310124173.3A CN116239558A (en) | 2023-02-16 | 2023-02-16 | Preparation method of eriodictyol |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116239558A true CN116239558A (en) | 2023-06-09 |
Family
ID=86629180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310124173.3A Pending CN116239558A (en) | 2023-02-16 | 2023-02-16 | Preparation method of eriodictyol |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116239558A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145670A (en) * | 2013-01-21 | 2013-06-12 | 李玉山 | Semisynthesis luteolin preparation new process |
CN105348245A (en) * | 2015-12-01 | 2016-02-24 | 陕西嘉禾生物科技股份有限公司 | Eriodictyol synthesis method |
CN112851616A (en) * | 2021-01-25 | 2021-05-28 | 三原润禾生物科技有限公司 | Semi-synthesis method of eriodictyol |
-
2023
- 2023-02-16 CN CN202310124173.3A patent/CN116239558A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145670A (en) * | 2013-01-21 | 2013-06-12 | 李玉山 | Semisynthesis luteolin preparation new process |
CN105348245A (en) * | 2015-12-01 | 2016-02-24 | 陕西嘉禾生物科技股份有限公司 | Eriodictyol synthesis method |
CN112851616A (en) * | 2021-01-25 | 2021-05-28 | 三原润禾生物科技有限公司 | Semi-synthesis method of eriodictyol |
Non-Patent Citations (3)
Title |
---|
MAURIZIO BARONTINI ET AL.: "Selective and efficient oxidative modifications of flavonoids with 2-iodoxybenzoic acid (IBX)", TETRAHEDRON, vol. 66, no. 32, 15 June 2010 (2010-06-15), pages 6047 - 6053, XP027142124 * |
SEBASTIAN STRYCH ET AL.: "Biomimetic Synthesis of Santalin A, B and Santarubin A, B, the Major Colorants of Red Sandalwood", ANGEW. CHEM. INT. ED., vol. 52, no. 36, 10 June 2013 (2013-06-10), pages 15 - 16, XP072072684, DOI: 10.1002/anie.201302317 * |
尤启东 等: "中华医学百科全书 药物化学", 31 December 2022, 中国协和医科大学出版社, pages: 165 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104250232A (en) | Preparation method of parecoxib sodium | |
JP2015145375A (en) | Method of producing 2-methoxymethyl-1,4-benzenediamine | |
CN110330500B (en) | Stereoselective synthesis method of 6 beta-hydroxy-7, 8-dihydro-morphine derivative | |
CN102471302A (en) | Preparation process of dronedarone and its salts | |
CN116239558A (en) | Preparation method of eriodictyol | |
CN106883206A (en) | Method for synthesizing coumarin by catalyzing (E) -o-hydroxycinnamaldehyde derivative with aza-carbene | |
CN108164423B (en) | Preparation method of naftifine hydrochloride | |
CN107011354B (en) | Preparation method of 5-isosorbide mononitrate | |
CN111100042B (en) | Preparation method of 2-methoxy-5-sulfonamide benzoic acid | |
CN111116493B (en) | Method for preparing Apabetalone, intermediate and preparation method of intermediate | |
CN111747879B (en) | Large-process synthesis method of erexib | |
CN110092751B (en) | Synthesis method of 2-alkyl quinoline | |
CN109265385B (en) | Synthesis process of chiral catalyst | |
CN116135848B (en) | Coumarin compound and preparation method and application thereof | |
CN114702408B (en) | Preparation method and application of clenbuterol impurity | |
CN115583902B (en) | Preparation method of alkynyl thioether compound | |
CN113754715B (en) | Optical selective process synthesis method of (5R) -5-hydroxyl triptolide | |
CN115504862B (en) | Preparation method of cannabigerol | |
CN112939855B (en) | Process for preparing 1, 4-dihydropyridine derivatives containing azulene ring structure | |
CN111747874B (en) | Ericoxib intermediate and preparation method and application thereof | |
CN103508999A (en) | Maxacalcitol synthesizing intermediate and preparation method and application thereof | |
CN109776415B (en) | Preparation method of Roxadustat intermediate | |
CN111662260B (en) | Synthetic method of natural product saffloneoside | |
WO2023001088A1 (en) | Preparation method of 3- (2, 2, 2-trifluoroethyl) pyrrolidine hydrochloride | |
CN112679328B (en) | Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |